Brainsway (BWAY) Operating Leases (2023 - 2026)

Brainsway posted quarterly Operating Leases of $5.6 million for Q1 2026, down 2.46% on a QoQ basis from $5.7 million in Q4 2025.

Brainsway (BWAY) has 4 years of Operating Leases data on file, last reported at $5.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (changed N/A YoY), and the FY2025 full-year result was $5.7 million, up 2.1% from the prior year.
  • Operating Leases for Q1 2026 stood at $5.6 million, down from $5.7 million in the prior quarter.
  • Across five years, Operating Leases topped out at $5.7 million in Q4 2025 and bottomed at $239000.0 in Q4 2023.
  • The 4-year median for Operating Leases is $5.6 million (2024), against an average of $4.3 million.
  • The widest annual swing landed in 2024, when Operating Leases jumped 2253.14%; it then gained 2.1% in 2025.
  • A 4-year view of Operating Leases shows it stood at $239000.0 in 2023, then surged by 2253.14% to $5.6 million in 2024, then grew by 2.1% to $5.7 million in 2025, then dropped by 2.46% to $5.6 million in 2026.
  • The last three Operating Leases figures came in at $5.6 million (Q1 2026), $5.7 million (Q4 2025), and $5.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.60 Mn
Dec 31, 2025 5.74 Mn
Dec 31, 2024 5.62 Mn
Dec 31, 2023 239,000.00